Related Experiment Videos
Total stepwise solid-phase synthesis of oligonucleotide-(3'-->N)-peptide conjugates
Dmitry A Stetsenko1, Andrey D Malakhov, Michael J Gait
1Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 2QH, UK.
Organic Letters
|September 14, 2002
Summary
We developed a solid-phase synthesis for oligonucleotide-peptide conjugates using controlled pore glass or polystyrene supports. This method efficiently creates conjugates for potential therapeutic applications, including cell penetration studies.
Area of Science:
- Oligonucleotide chemistry
- Peptide synthesis
- Bioconjugation
Background:
- Oligonucleotide-peptide conjugates are valuable tools in molecular biology and medicine.
- Previous methods for synthesizing these conjugates have limitations in efficiency and scope.
- Developing robust synthetic routes is crucial for advancing therapeutic applications.
Purpose of the Study:
- To establish an efficient solid-phase synthesis for oligonucleotide-peptide conjugates.
- To create a versatile platform for conjugating various peptides and oligonucleotide modifications.
- To enable the incorporation of labels for studying cellular uptake.
Main Methods:
- Stepwise solid-phase synthesis utilizing controlled pore glass or macroporous polystyrene beads.
- Employing a homoserine linker approach for conjugate formation.
- Synthesizing conjugates with different cell-penetrating peptides and oligonucleotide backbones (phosphodiesters, phosphorothioates).
Main Results:
- Demonstrated an efficient and stepwise solid-phase synthesis of oligonucleotide-peptide conjugates.
- Successfully prepared a range of conjugates with diverse peptide and oligonucleotide components.
- Showcased the ability to incorporate fluorescent labels for cellular uptake analysis.
Conclusions:
- The described solid-phase synthesis provides an efficient route to oligonucleotide-peptide conjugates.
- This method supports the conjugation of various peptides and modified oligonucleotides.
- The platform facilitates the development of novel oligonucleotide-based therapeutics and research tools.